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httpThe current management of isolated degenerative
femoral artery aneurysms is too aggressive for their
natural history
Peter F. Lawrence, MD,a Michael P. Harlander-Locke, BS,a Gustavo S. Oderich, MD,b
Misty D. Humphries, MD,c Gregory J. Landry, MD,d Jeffrey L. Ballard, MD,e and
Christopher J. Abularrage, MD,f for The Vascular Low-Frequency Disease Consortium, Los Angeles, Calif;
Rochester, Minn; Salt Lake City, Utah; Portland, Ore; Orange, Calif; and Baltimore, Md
Background: Previous studies have combined anastomotic, catheter-induced, and atherosclerotic isolated femoral artery
aneurysms (FAAs) to achieve adequate numbers for analysis and have recommended repair of asymptomatic FAAs with
diameters $2.5 cm and all symptomatic FAAs. This study evaluated the contemporary management of isolated FAAs.
Methods: Patients with FAAs were evaluated using a standardized, prospectively maintained database by a research
consortium.
Results: From 2002 to 2012, 236 FAAs were identiﬁed in 182 patients (mean age, 72 years; male-to-female ratio, 16:1) at
eight institutions. The mean nonoperative mean diameter was 2.86 0.7 cm, and the operative diameter was 3.36 1.5 cm.
FAA location was the common femoral artery in 191, superﬁcial femoral artery (SFA) in 34, and profunda femoris artery
in 11. Synchronous aneurysms (mean, 1.7 per patient) occurred in the aorta (n[ 113), in the iliac (n[ 109), popliteal
(n[ 86), and hypogastric (n[ 56) arteries, and in the contralateral common femoral artery (n[ 34), SFA (n[ 9), and
profunda femoris artery (n [ 2). Of the aneurysms repaired, 66% were asymptomatic; other indications for repair were
claudication (18%), local pain (8%), nerve compression (3%), rupture (2%), acute thrombosis (1%), and rest pain (0.5%).
Acute aneurysm-related complications (rupture, thrombosis, embolus) were associated (P < .05) with FAA diameter
>4 cm and intraluminal thrombus, but not location. Mean diameter of asymptomatic aneurysms that developed acute
complications was 5.7 6 1.3 cm for rupture, 4 6 1.1 cm for thrombosis, and 3.5 cm for embolus. Repair was by inter-
position or bypass graft in 177 FAAs and by endovascular repair in three SFA aneurysms. Two perioperative deaths, of
myocardial infarction and multisystem organ failure, occurred at 30 days. Operative complications included wound
infection (6%), seroma (3%), and bleeding (2%). No amputations occurred through 5 years in the operative or nonoperative
groups. Survival in operated-on patients was 99% (n[ 138) at 3 months, 92% at 1 year, and 81% (n[ 20) at 5 years.
Conclusions: This largest study of isolated FAAs demonstrates that (1) acute complications did not occur in FAAs
#3.5 cm, repair criteria of asymptomatic FAAs should be changed to >3.5 cm, and chronic intraluminal thrombus should
reduce the threshold for repair, and that (2) current indications for symptomatic FAA repair result in low morbidity and
should remain unchanged. (J Vasc Surg 2014;59:343-9.)Degenerative femoral artery aneurysms (FAAs) are rare; techniques and operative and endovascular procedures were
they occur in approximately ﬁve patients per 100,000.1
Current recommendations for treatment of asymptomatic
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mix anastomotic, atherosclerotic, mycotic, post-traumatic,
and pseudoaneurysms.4-6 These studies also emphasize
that the natural history of FAAs remains relatively unknown,
so there is little consensus regarding the treatment criteria
for asymptomatic FAAs. The objective of our study was to
examine the current management and outcomes of degener-
ative FAAs in a large cohort of patients, using a standardized
multi-institutional approach, and to re-examine the criteria
for repair of asymptomatic, isolated FAAs.METHODS
Literature review and analysis of local experience. A
MEDLINE search was conducted using the keywords
degenerative, atherosclerotic, arteriosclerotic, true, femoral,
and aneurysm to identify English-language articles pub-
lished in the past 30 years related to FAAs. Demographic,
diagnostic, preprocedural imaging, procedural details, and
postoperative complications and outcomes considered
important in each of the studies were entered into a data
collection worksheet.343
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Vascular Surgery Clinical Practice Guideline for aneurysms
as a focal, isolated dilatation of all three layers of the arterial
wall that measured at least 1.5 times the diameter of the
disease-free proximal adjacent arterial segment.7 The anal-
ysis excluded patients with continuous aneurysms origi-
nating in the external iliac artery or extending into the
popliteal arteries because they met the deﬁnition of arterio-
megaly, which may have a different natural history.
After approval by the University of California, Los
Angeles (UCLA) Institutional Review Board (IRB), patients
treated at UCLA during a 10-year interval from 2002 to
2012 with common femoral artery (CFA), profunda femoris
artery (PFA), and superﬁcial femoral artery (SFA) aneurysms
were entered into the database using International Classiﬁ-
cation of Diseases, 9th edition (ICD-9) codes (442.3,
442.8) and Current Procedural Terminology (CPT; Amer-
ican Medical Association, Chicago, Ill) procedural codes
(37205, 37799, 37226, 35141, 35142).
Patients with degenerative FAAs were reviewed for
demographic, comorbidities, and risk factors, along with
perioperative, operative, pathologic, initial, and long-term
outcomes. Imaging studies, operative records, endovascu-
lar and open surgery operative reports, and pathologic
reports were used to differentiate pseudoaneurysms,
mycotic, anastomotic, and post-traumatic aneurysms from
atherosclerotic FAAs. The UCLA experience with FAAs
was presented at the 2010 Southern California Vascular
Surgery Society Annual Meeting.
Database development. Key questions that could not
be answered from the single-institution UCLA study of
FAAs, due to small patient numbers, became the basis for an
expanded new multi-institutional study. The existing data-
base was revised to address the added information learned
from the single-institution study. Invitations to participate
in the multi-institutional study were sent to members of
local and regional vascular societies, including the Southern
California Vascular Surgery Society, the Rocky Mountain
Vascular Society, and the Western Vascular Society, as well
as institutions within the United States that had recently
published reports on peripheral aneurysms.
Surgeons and institutions who expressed an interest in
participating in a multi-institutional FAA study were sent
study packages, which consisted of a summary of the
UCLA single-institution experience, speciﬁc information
to aid in obtaining IRB approval, a database collection
form, and ICD-9 (442.3, 442.8) and CPT (37205,
37799, 37226, 35141, 35142) codes that would enable
each institution or surgeon to identify patients who had
been treated for isolated FAAs. Participating institutions
and surgeons were assisted in the IRB approval process
by members of the UCLA multi-institutional study team,
who were available throughout the entire study.
Database management. Once the study was approved
at each institution, data were collected, deidentiﬁed, sent to
a UCLA server, and stored in a password-encrypted central
database managed by the Vascular Surgery Division at
UCLA. Submitted patient data from each institution wereexamined for accuracy and completeness; incomplete
entries were resolved with each institution.
Statistics. All data were maintained in an Excel 14 data-
base (Microsoft Corp, Redmond, Wash). Statistical analysis
was performed using SPSS 20.0 software (IBM Corp,
Armonk, NY). Continuous variables are presented as
mean 6 standard deviation, unless noted otherwise. Differ-
ences among subgroups were analyzed using independent
Student t-test, Kruskal-Wallis test, Mann-Whitney U test,
and analysis of variance test. Differences among subgroups
of noncontinuous variables were analyzed using the c2 test
or the Fisher exact test. Multivariable analysis was performed
using binary and multinomial logistic regression. Cochran
and Mantel-Haenszel methods were used for hazard ratios
and 95% conﬁdence intervals. All time-dependent variables
were analyzed using Kaplan-Meier life-tables. A P value
of <.05 was considered signiﬁcant.
RESULTS
Demographics and risk factors. Between 2002 and
2012, 236 isolated degenerative FAAs were identiﬁed in
182 patients at eight institutions from different regions
of the United States. The mean age at diagnosis was
72 6 10 years (range, 21-89 years). FAAs occurred
predominantly in men (male-to-female ratio, 16:1). Risk
factors and comorbidities are summarized in Table I and
included smoking, hypertension, hyperlipidemia, coronary
artery disease, peripheral arterial disease (other than the
aneurysm), diabetes mellitus, and dialysis-dependent
chronic renal insufﬁciency.
The distribution of aneurysms in the three anatomic
segments of the femoral artery (CFA, PFA, and SFA) is
shown in Fig 1. Synchronous and metachronous aneurysms
were identiﬁed in the aorta as well as unilaterally and bilat-
erally in the external iliac, hypogastric, PFA, SFA, and
popliteal artery (Fig 1). At the initial evaluation, 156 aneu-
rysms (66%) were asymptomatic; the clinical presentation
of all FAA patients and aneurysms is reported in Table II.
Large FAA diameter, presence of intraluminal thrombus
in the aneurysm, and PFA aneurysms were all signiﬁcantly
more common among symptomatic patients (Table III).
Preoperative data. In addition to FAA identiﬁcation
by physical exam, imaging modalities that were used to
conﬁrm the diagnosis, determine location and size, and
assess for intraluminal thrombus in the FAAs included
computed tomography in 127 (70%), duplex ultrasound
imaging in 70 (38%), conventional angiography in 57
(31%), and magnetic resonance imaging in 18 (10%). The
mean aneurysm diameter for all patients was 3.2 6 1.4 cm
(maximum, 10 cm). The mean (standard error of the
mean) preoperative ankle-brachial index was 0.93 6 0.02.
The management used for patients with degenerative
FAAs, since the initial evaluation, is shown in Fig 2. After
the initial evaluation, 114 patients with 156 FAAs were
observed without deﬁnitive treatment. Of these patients
initially managed conservatively, 73 (64%) later underwent
operative repair for indications, including development of
intraluminal thrombus in 46, size increase to $ 2.5 cm in
Fig 1. The locations and distribution are shown of degenerative
femoral artery aneurysms (FAAs; dotted boxes) and additional
synchronous and metachronous aneurysms. Forty-seven patients
(26%) had bilateral degenerative FAAs.
Table II. The clinical presentation of all patients and
degenerative femoral artery aneurysms (FAAs) at the
initial evaluation
Variablea Patients (n ¼ 182) Aneurysms (n ¼ 236)
Diameter, cm 3.2 6 1.4 3.2 6 1.4
Asymptomatic 114 (63) 156 (66)
Palpable mass 42 (29) 55 (23)
Claudication 43 (22) 43 (18)
Local pain 19 (10) 19 (8)
Rupture 3 (2) 3 (1)
Thrombosis 2 (1) 2 (1)
Rest pain 1 (1) 1 (<1)
aContinuous data are shown as mean 6 standard deviation and categoric
data as number (%).
Table I. Demographics and cardiovascular risk factors
for patients with degenerative femoral artery aneurysms
(FAAs)
Variable Mean 6 SD or No. (%) (N ¼ 182)
Age, years 72 6 10
Male gender 171 (94)
Cigarette smoking 139 (76)
Hypertension 136 (75)
Hyperlipidemia 97 (53)
Coronary artery disease 92 (51)
Peripheral arterial disease 55 (30)
Diabetes 27 (15)
Dialysis-dependent 3 (2)
SD, Standard deviation.
Table III. Differences and similarities in patient
characteristics between patients who were symptomatic
and asymptomatic at the initial evaluation
Variablea
Symptomatic
(n ¼ 68)
Asymptomatic
(n ¼ 114) P
Age, years 72 6 10 72 6 10 .92
Male gender, % 96 95 .551
FAA
Max diameter, cm 3.6 6 1.9 2.9 6 0.8 <.001
Length, cm 5.8 6 3.4 4.4 6 2.2 .07
Intraluminal thrombus, % 66 25 <.001
PFA aneurysm, % 10 2 .005
FAA, Femoral artery aneurysm; PFA, profundus femoris artery.
aContinous data are shown as mean 6 standard deviation and categoric data
as indicated.
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(Fig 3). Of the 12 patients who developed acute complica-
tions, 7 (6%) underwent emergent repair for FAA rupture
(mean FAA diameter, 5.7 6 1.3 cm), 3 (3%) for FAA
thrombosis (mean FAA diameter, 4.0 6 1.1 cm), and 2
(2%) for FAA embolization (mean FAA diameter, 3.5 cm).
Age, diameter, and the presence of intraluminal thrombus
were statistically signiﬁcant factors associated with acute
aneurysm-related complications and were also indications
for operative repair in patients who were asymptomatic at
the initial evaluation (Table IV).
Operative data. Surgical repair was performed in 141
patients with 180 aneurysms (76%; Fig 3), with 177 FAAs
(98%) treated by an open surgical approach; only threepatients (2%) underwent percutaneous endovascular repair
of their SFA aneurysms. The most frequent indications for
repair were pain, intraluminal thrombus, and size $2.5 cm;
other indications are reported in Table V. Open surgical
procedures included interposition graft in 142 FAAs (80%)
and bypass in 35 (20%). Bypasses were most frequently
from the external iliac artery to the CFA (n ¼ 12 [34%]),
proximal SFA (n ¼ 9 [26%]), and PFA (n ¼ 8 [23%]) but
also from the SFA to the tibial artery (n ¼ 2 [6%]).
Aneurysms that were surgically repaired were signiﬁcantly
greater in diameter than those managed conservatively
(operative FAA mean diameter, 3.3 6 1.5 cm; P ¼ .001).
One patient died intraoperatively of multisystem organ
failure.
Perioperative data. The 30-day mortality for opera-
tive patients was 1.1% (n ¼ 2; Fig 2). Major postoperative
complications developed in 27 patients (20%), including
wound infection/seroma/hematoma in 17 (12%), respi-
ratory failure in 4 (3%), acute lower extremity ischemia in 2
(1.5%), acute renal insufﬁciency in 2 (1.5%), compartment
syndrome in 1 (1%), and deep venous thrombosis in 1
(1%). No correlation was found between symptomatic or
acute presentation and perioperative complications. The
median hospital length of stay was 4 days (mean, 7 6
4 days).
Initial Evaluation
182 Patients
236 Femoral Artery Aneurysms (FAA)
Mean diameter: 3.2 ± 1.4 cm
Range: 1 - 10 cm
Repaired
68 Patients, 80 FAA
(62 CFA, 10 SFA, 8 PFA)
Symptomatic: n = 71 FAA
Asymptomatic: n = 9 FAA
Mean diameter: 3.6 ± 1.9 cm
Range: 1.5 - 10cm
Observed
114 Patients, 156 FAA
(129 CFA, 24 SFA, 3 PFA)
Mean diameter: 2.9 ± .8 cm
Range: 1 - 5.2 cm
Operative repair
Endovascular repair: 3 FAA
Mean diameter: 2.4 ± .2 cm
Open repair: 77 FAA
Mean diameter: 3.6 ± 1.7 cm
Indication
61 Patients
Size: 35 FAA (32 FAA >2.5cm)
Intraluminal thrombus: 46 FAA
Growth rate: 7 FAA
Operative repair
Open repair: 12 FAA
Mean diameter: 5.0±1.5 cm
Range: 3.5-5.2 cm
Acute Complication
12 Patients
Rupture: 7 FAA
Embolus: 3 FAA
Thrombosis: 2 FAA
Operative repair
Open repair: 88 FAA
Mean diameter: 2.9±.6 cm
Range: 2-4.6 cm
Observation
41 Patients, 56 FAA
Mean diameter 2.8 ± .7 cm
Range: 1 - 4.7 cm
Mean follow-up: 49 mo.
Range: 1 – 93 mo.
Repaired
Fig 2. Flowchart shows the management used for patients with degenerative femoral artery aneurysms (FAAs). CFA,
Common femoral artery; PFA, profundus femoral artery; SFA, superﬁcial femoral artery.
Fig 3. Kaplan-Meier life-table shows freedom from acute
complication and operative repair for patients asymptomatic at the
initial evaluation.
Table IV. Multivariable analysis of factors associated
with acute aneurysm-related complications and
indications for operative repair in patients who were
asymptomatic at the initial evaluation
Variable HR (95% CI) P
Diameter $4 cm 5.192 (1.535-17.564) <.001
Intraluminal thrombus 4.386 (1.221-15.756) <.001
Age <60 years 3.882 (1.382-13.224) .004
Ipsilateral FAA 3.083 (0.874-10.878) .08
Rapid expansion 1.384 (0.146-18.640) .741
Contralateral FAA 1.180 (0.343-4.058) .793
Popliteal aneurysm .603 (0.186-1.961) .755
CI, Conﬁdence interval; FAA, femoral artery aneurysm; HR, hazard ratio.
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surgical repair of their FAAs, 179 (99%) were available
for 30-day follow-up. The cumulative survival for
operated-on and observed patients was comparable out to
5-years of follow-up (Fig 4). One patient developed an
open wound infection within 6 months of surgery. None
developed critical limb ischemia or underwent an ampu-
tation during the follow-up period. The mean
ankle-brachial index value postoperatively for the patient’s
index limb at 1 year was 0.91. The mean length of
follow-up was 49 months (range, 1-93 months). One
patient (1%) had femoral graft-related complications, and
35 patients (27%) died of nonaneurysmal-related causes.The life-table cumulative survival rate of all patients was
94.5% at 6 months and 61.1% at 5 years (Fig 2), and limb
salvage was 100% in patients who remained alive during
the 5-year follow-up period. Survival between symptomatic
and asymptomatic patients did not differ signiﬁcantly
(Fig 5).
DISCUSSION
This study represents the largest series of degenerative
FAAs reported in the literature, but equally important is
that it assesses patients during the last 10 years, in an
era where sophisticated imaging, such as duplex ultra-
sound, computed tomography, and magnetic resonance
angiography, are routinely used and where surgery and
Table V. Indications for repair of all degenerative
femoral artery aneurysms (FAAs)
Variable No. (%) (N ¼ 180)
Pain 62 (34)
Intraluminal thrombus 49 (27)
Size $2.5 cm 41 (23)
Rupture 10 (6)
Enlargement 7 (4)
Thrombosis 5 (3)
Femoral nerve compression 4 (2)
Distal embolization 2 (1)
Fig 4. Kaplan-Meier life-table shows the survival rates of patients
managed operatively compared with nonoperatively. A Tarone-
Ware test was used to determine the degree of difference.
Fig 5. Kaplan-Meier life-table shows survival rates of patients with
asymptomatic aneurysms compared with symptomatic aneurysms.
A Tarone-Ware test was used to determine the degree of
difference.
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The conclusions of this study are that asymptomatic degen-
erative FAAs rarely develop a complication unless they are
$ 3.5 cm and have intraluminal thrombus. However, the
location of FAAs that developed complications, whether
they originated in the CFA, PFA, or SFA, was not signiﬁ-
cant, and the behavior of the aneurysms was not different,
based on location, as long as the aneurysms were isolated.
The natural history of degenerative FAAs is not well
documented because of their low frequency, so many
authors base treatment guidelines on popliteal artery aneu-
rysms. They assume that peripheral artery aneurysms
behave in a similar manner and, therefore, recommend
similar criteria for repair of FAAs.6,8 Most current textbook
recommendations for treatment of asymptomatic FAAs use
a size $2.5 cm and FAAs that are found to be rapidly
enlarging.8 These criteria became the “standard” during
an era when precise vascular imaging was often not avail-
able and pseudoaneurysms and anastomotic graft aneu-
rysms were mixed with degenerative aneurysms.
The emergence of high-quality noninvasive vascular
imaging provides more objective methods of determining
the etiology, sizing FAAs, assessing for intraluminal
thrombus, and deﬁning their anatomy. Our results indicate
that FAAs have a more benign natural history than popli-
teal artery aneurysms, contradicting the assumptions
underlying the existing recommendations, which assume
the two are similar.9,10Acute complications in otherwise asymptomatic FAAs
are exceedingly rare, and thrombosis and embolus are
more common than rupture.11-13 The incidence of these
complications in prior studies is variable, and some studies
correlated complications with speciﬁc femoral vessels. In
one of the earliest reports of multiple etiology FAAs, pub-
lished by Cutler and Darling,3 acute complications
occurred in 43%, and thus, aggressive surgical treatment
for all patients was advocated. In contrast, Graham et al14
reviewed the results of 172 arteriosclerotic FAAs in 100
patients and found that only three patients managed
conservatively had complications and thus advocated
a less aggressive treatment approach after their experience
demonstrated a much more benign natural history. FAA
complications in our series occurred primarily in patients
with intraluminal thrombus in the aneurysm, and none
occurred in aneurysms <3.5 cm in maximum diameter.
Prior studies have found the incidence of thrombosis or
embolus was 15% in CFA, 45% in PFA, and 26% in SFA
aneurysms.15,16 These authors suggested that the abnor-
mally high rate for PFA thrombosis and embolus was the
result of the aneurysm’s location deep in the thigh, so
most PFA aneurysms go undetected until they become
large and symptomatic. Only ﬁve patients (3%) in our study
had thrombosis or embolus, with no signiﬁcant correlation
with the speciﬁc section of femoral artery involved.
In our series, rupture occurred with similar frequently
as thrombosis or embolus and in a higher percentage of
PFA and SFA aneurysms; when occurred in a CFA, the
aneurysm was >5 cm in diameter. Although only w40
cases of isolated SFA aneurysms have been reported,
some authors have recommended repair of all SFA aneu-
rysms to avoid rupture and embolization12; our series
found that only 4% of FAAs ruptured. Our results suggest
that aneurysms <3.5 cm in maximum diameter have a low
risk of rupture and can be observed and monitored for
evidence of rapid aneurysm expansion.
The signiﬁcance of intraluminal thrombus and its
contribution to acute complications has been postulated,
based on its embolic potential, yet no prior studies have
demonstrated a signiﬁcant relationship.4 We found that
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symptomatic patients and asymptomatic patients who then
developed an acute embolic or thrombolytic complication.
Multivariable analysis showed that FAAs >4 cm with intra-
luminal thrombus are at signiﬁcant risk for complications;
therefore, we recommend that intraluminal thrombus be
a factor used when deciding to treat an FAA and that the
presence of thrombus should reduce the size threshold
for elective repair.
The association between FAAs and abdominal aortic
aneurysms and other peripheral arterial aneurysms has
been well established, but the incidence varies between
studies15,17; synchronous femoral and aortic aneurysms
occur in 50% to 90%,9,18 synchronous popliteal artery
aneurysms in 27% to 44%,15,17 and synchronous contralat-
eral FAAs inw26% to 50%.4,19 The frequency of aortic and
contralateral femoral aneurysms in our series are compa-
rable to the recently reported results of Piffaretti et al,4
who found that 26% of FAA patients had bilateral FAAs
and 48% had additional central and peripheral artery aneu-
rysms. The high prevalence of additional arterial aneurysms
indicates that degenerative FAAs are a marker for systemic
aneurysmal disease.
Our assumption is that the large range of reported
prevalences for these aneurysms is the result of variations
in arterial screening or follow-up imaging of the abdominal
and contralateral peripheral vessels. We therefore believe
the true prevalence of synchronous and metachronous
aneurysms may be much higher than the current literature
suggests. The implication of not identifying all aneurysms,
particularly those that are asymptomatic, is that the rate of
developing an acute complication may be overestimated.
We recommend that all patients found to have degenera-
tive FAAs be screened for additional arterial aneurysms
with abdominal and lower extremity duplex ultrasound or
computed tomography imaging.
One of the main limitations of this study is its retro-
spective design, which precludes capture of all FAAs,
including those untreated. Most studies are limited to
patients who were referred to centers that treat FAAs;
consequently, a large number of asymptomatic FAAs may
be undiagnosed or untreated. The true prevalence of
FAAs would require a national screening study, which is
presently not economically feasible and thereby limits our
ability to measure the true prevalence of synchronous aneu-
rysms. The true natural history of degenerative FAAs also
remains relatively unknown. To conclusively determine
the risk of rupture, thrombosis, and embolism would
require a prospective trial of asymptomatic aneurysms
>2.5 cm in diameter, which are observed indeﬁnitely.
CONCLUSIONS
This large study of isolated degenerative FAAs demon-
strates that acute complications are rare and did not occur
in aneurysms <3.5 cm in diameter. We therefore believe
that the criteria for repair of asymptomatic FAAs should
be changed to $3.5 cm. Intraluminal thrombus is an addi-
tional indication for elective repair and should be a factorwhen considering the size threshold for elective FAA
repair. The current indications for symptomatic FAA repair
result in low morbidity and should remain unchanged.
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your recommendation of a new threshold of 3.5 cm, which, if I
understood well, is based on the observation of a cohort of patients
where you operated on patients who reached the 2.5 threshold.
And, this doesn’t make a lot of sense to me, because I would rather
make this recommendation after following a cohort of patients
where surgery was delayed at the 3.5 threshold and no complica-
tions were observed.
Dr Gustavo Oderich. The average diameter in the cohort
who underwent observation was 3 cm, and after a mean follow-
up of 49 months, there were no complications among patients
with aneurysms <3.5 cm. Yes, we have not followed patients indef-
initely and 61 of 114 patients were repaired for “growth” or size
>2.5 cm, with average size of 2.9 cm in this subset of patients. If
we look at the 12 patients that had an acute event, the average
size was 5 cm; and in fact, there was one patient with a 3.5-cm aneu-
rysm, and the others had aneurysms signiﬁcantly larger than 4 cm.
So, the best recommendations we can make based on this
retrospective review are that there were no complications for aneu-
rysms <3.5 cm, and therefore this size can be considered as a new
threshold for repair. I do agree the study has limitations due to the
design and lack of predeﬁned protocol, but it does show that
complications have not occurred in smaller aneurysms, and most
certainly there is little evidence that repair is really needed earlier
for smaller aneurysms.
Dr Carmo. My second question is: would you recommend
a lower threshold for patients with a particularly active life, for
example, riding a bike or gardening, where hip movements can
have some impact?
Dr Oderich. This study also shows that even in a multicenter
experience, the repair can be done safely with very low mortality
and morbidity. So, it’s difﬁcult to argue not to repair a patient
that is young, healthy, and has a very active lifestyle as you out-
lined. Our data have shown that age <60 years old was indepen-
dently associated with higher rates of aneurysm complications. I
do think that it is reasonable to repair the aneurysm at a smaller
size, larger than 2.5 cm, in a younger patient, particularly if there
is growth or any concern due to thrombus.
Dr Kamran Karimi (Cedar Falls, Iowa). Would your
threshold of repair be different in a common femoral artery aneu-
rysm if the superﬁcial femoral artery is occluded?
Dr Oderich. Good question. We analyzed the threshold as
a group. But, evidently as we move distal on the circulation, that
may not necessarily apply. The few superﬁcial femoral artery aneu-
rysms included in this study were in the very proximal, encroachingthe common femoral artery. For distal superior femoral artery
aneurysms, we use the same recommendations as for popliteal
aneurysms.
Dr George Hamilton (London, United Kingdom). You’ve
got potentially two groups here. I just wonder whether you
analyzed for the effect of best medical therapy and particularly
the use of statins. Did you ﬁnd a difference between the two? In
other words, the groups that you didn’t operate on that didn’t
expand and the group that did.
Dr Oderich. Well, the credit really goes to Dr Lawrence. He
has a number of other ongoing projects, and I would welcome the
membership to contact him if interested in collaborating.
Dr Hamilton. The question was really about the use of statins
and best medical therapy, not endovascular therapy.
Dr Oderich. To answer your question, we have no informa-
tion on medical therapy.
Dr George Meier (Cincinnati, Ohio). Gustavo, I noticed that
your length of stay was 7 days on average. Was that due to outliers,
or were they really in the hospital that long? It seems longer than I
would expect.
Dr Oderich. I agree. One limitation of the data set is that
there is a number of patients who had concomitant aortic repair,
explaining the longer length of stay. And, perhaps Dr Lawrence
can comment on that, but that is a limitation of the data set and
I don’t have the information on the details of that.
Dr Peter Lawrence (Los Angeles, Calif). This database
approach provides a very large data set, but there are some limita-
tions to analysis. The prolonged length of stay reasons are unique
to each institution, but they are skewed by the emergent femoral
aneurysms with thrombolysis and amputation. Also this is
a 10-year study, so the data go back to an era when length of
stay was not such a big issue. I believe that length of stay would
be much shorter if the data were collected in 2013, particularly
for those patients who had an elective femoral aneurysm repair.
Dr Rombout Kruse (Zwolle, The Netherlands). Very inter-
esting to see these diseases being treated in your presentation
that are so rare. I have a question about the groin infections. If I
have it correct, you saw 12% groin infections. Did you use in
your study only Dacron, or did you also use venous interposition
or other materials?
Dr Oderich. The rate of 12 complications actually includes
a combination of all wound-related complications and that consists
of seromas, lymphatic leaks, and infections. The most common
conduit used is polyester graft. Vein has not been used to replace
at least in a larger number of patients.
